News

SAN DIEGO–(BUSINESS WIRE)–Vaxiion Therapeutics Initiates Phase 1 Clinical Trial of VAX014 for the Treatment of Non-muscle Invasive Bladder Cancer in the United States […]

Many paths lead to a career in science, students are told […]

LA JOLLA?Advanced pancreatic cancer is often symptomless, leading to late diagnosis only after metastases have spread throughout the body. Additionally, tumor cells are encased in a ?protective shield,? a microenvironment conferring resistance to many … […]

LA JOLLA?Advanced pancreatic cancer is often symptomless, leading to late diagnosis only after metastases have spread throughout the body. Additionally, tumor cells are encased in a ?protective shield,? a microenvironment conferring resistance to many … […]

Turning Point Therapeutics raised more than $166 million in its IPO, pricing at the top of its range and putting nearly 2 million more shares into the public markets than it had initially planned. Strong demand ahead of the offering prompted the compan… […]

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today ann… […]

LA JOLLA?The Salk Institute?s Harnessing Plants Initiative to combat climate change using plants, led by Professor Joanne Chory, executive director of the Harnessing Plants Initiative, will receive funding of more than $35 million from over 10 individu… […]

About 25 percent of the carbon dioxide added to the air by human activity could be removed, researchers say […]

LA JOLLA?Three Salk Institute faculty members have been promoted after the latest round of faculty reviews determined they are scientific leaders who have made original, innovative and notable contributions to biological research.
The post Salk promote… […]

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics,?an innovative biotechnology company focusing on research and production of wellness compounds, announced the closing of the first round of equity funding for its research projects. The company raised $7.5 M?… […]

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/opioid?src=hash" target="_blank"gt;#opioidlt;/agt;–Ensysce Biosciences Inc.,?a clinical phase drug development company with innovative technologies to curb prescrip… […]

CARLSBAD, Calif.–(BUSINESS WIRE)–SleepScore Labs Announces New Brand Ambassador Todd Clever […]

SAN DIEGO–(BUSINESS WIRE)–Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, highlighted new data from multiple studies of rezafungin, the company?s lead investigational compo… […]

SAN DIEGO–(BUSINESS WIRE)–On March 11, 2019, ACEA Biosciences ? A Part of Agilent unveiled the new xCELLigence? RTCA ePacerTM during their workshop held at the Society of Toxicology (SOT) Annual Meeting in Baltimore. Human induced pluripotent stem ce… […]

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/fasterscience?src=hash" target="_blank"gt;#fastersciencelt;/agt;–Scientist.com, the online marketplace for outsourced research, announced today the launch of Trial … […]

Drug discovery startup Insitro burst onto the scene last year with ambitions of using machine learning techniques to find new therapies. Now the company has its first pharmaceutical partner. Gilead Sciences will work with Insitro to find medicines to t… […]

While fungal infections may seem like an annoyance rather than a serious health problem, sick people in hospitals and long-term care facilities are contracting potentially deadly infections that current treatments are failing to ameliorate, thanks to t… […]

LA JOLLA?Salk Professor Kay Tye has been recognized for her contributions and dedication to advancing science through research by being named to the Wylie Vale Chair.
The post Salk professor Kay Tye honored with endowed chair appeared first on Salk Ins… […]

SAN DIEGO–(BUSINESS WIRE)–Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the company has selected the antiviral conjugate (AVC) CB-012 as its first cl… […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc.?(Nasdaq:ALNY), the leading RNAi therapeutics company, announced today that the Company has initiated ILLUMINATE-B, a global Phase 3 pediatric study of lumasiran, an investigational, subcu… […]

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24Cell&src=ctag" target="_blank"gt;$Celllt;/agt; lt;a href="https://twitter.com/hashtag/Allele_Biotech?src=hash" target="_blank"gt;#Allele_… […]

Fate Therapeutics begins experimental testing of ‘natural killer’ cells in cancer […]